Cargando…

Fecal microbiota transplantation against irritable bowel syndrome? Rigorous randomized clinical trials are required

Halkjær et al searched systematically nine articles including 48 patients, and concluded that fecal microbiota transplantation (FMT) can be an ideal treatment option for irritable bowel syndrome (IBS) subjects. Regardless of the few successes in current traditional therapies (change in diet, herbal...

Descripción completa

Detalles Bibliográficos
Autor principal:	Abadi, Amin Talebi Bezmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Letters To The Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680168/ https://www.ncbi.nlm.nih.gov/pubmed/29152407 http://dx.doi.org/10.4292/wjgpt.v8.i4.208

Ejemplares similares

Comment on “Lack of Association Found between Helicobacter pylori Infection and Diarrhea-Predominant Irritable Bowel Syndrome: A Multicenter Retrospective Study”
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Furazolidone and Helicobacter pylori Treatment
por: Talebi Bezmin Abadi, Amin
Publicado: (2015)

Comment on “Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients”
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Mix Infections of Helicobacter pylori: A Major Risk Factor Affecting Genotyping Studies
por: Talebi Bezmin Abadi, Amin
Publicado: (2014)

Updated Helicobacter pylori Management in 2015
por: Abadi, Amin Talebi Bezmin
Publicado: (2016)

Type 2 diabetes and Helicobacter pylori infection: Starting point for the reality?
por: Abadi, Amin Talebi Bezmin
Publicado: (2015)

Comment on “Characteristics and Risk Factors of Helicobacter pylori Associated Gastritis: A Prospective Cross-Sectional Study in Northeast Thailand”
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Comment on “Bacteria in Cancer Therapy: Renaissance of an Old Concept”
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Call for global vaccine instead of Helicobacter pylori blind antibiotic therapy
por: Abadi, Amin Talebi Bezmin
Publicado: (2016)

Comment on “Helicobacter pylori Outer Membrane Protein 18 (Hp1125) Is Involved in Persistent Colonization by Evading Interferon-γ Signaling”
por: Talebi Bezmin Abadi, Amin, et al.
Publicado: (2015)

Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”
por: Kashani, Negin, et al.
Publicado: (2018)

Comment on “circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer”
por: Rahimi, Farid, et al.
Publicado: (2019)

Transparency and information sharing could help abate the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2020)

Can fecal microbiota transplantation cure irritable bowel syndrome?
por: Halkjær, Sofie Ingdam, et al.
Publicado: (2017)

Inefficiency of Rapid Urease Test for Confirmation of Helicobacter pylori
por: Abadi, Amin Talebi Bezmin, et al.
Publicado: (2011)

Considerable use of Furazolidone in Iran
por: Talebi Bezmin Abadi, Amin, et al.
Publicado: (2010)

Comment on “Gastric and colon metastasis from breast cancer: case report, review of the literature, and possible underlying mechanisms”
por: Talebi Bezmin Abadi, Amin
Publicado: (2017)

Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome
por: Wang, Yao, et al.
Publicado: (2019)

Fecal microbiota transplantation in irritable bowel syndrome: A meta-analysis of randomized controlled trials
por: Samuthpongtorn, Chatpol, et al.
Publicado: (2022)

Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21(st) century
por: El-Salhy, Magdy, et al.
Publicado: (2021)

Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation
por: El‐Salhy, Magdy, et al.
Publicado: (2022)

Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials
por: Wu, Jie, et al.
Publicado: (2022)

Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials
por: Zhao, Hui-jun, et al.
Publicado: (2022)

Fecal microbiota transplantation in patients with post-infectious irritable bowel syndrome: A randomized, clinical trial
por: Tkach, Sergii, et al.
Publicado: (2022)

Fecal microbiota transplantation for patients with irritable bowel syndrome: A meta-analysis protocol
por: Wen, Wenting, et al.
Publicado: (2018)

Simultaneous occurrence of seasonal influenza virus and SARS CoV-2 strains
por: Talebi Bezmin Abadi, A., et al.
Publicado: (2021)

Simultaneous occurrence of seasonal influenza virus and SARS CoV-2 strains
por: Talebi Bezmin Abadi, A., et al.
Publicado: (2021)

Novel Idea: Virulence-Based Therapy Against Helicobacter pylori Infection (Smart Therapy)
por: Talebi Bezmin Abadi, Amin
Publicado: (2014)

Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
por: El‐Salhy, Magdy, et al.
Publicado: (2020)

Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Jamshidi, Parnian, et al.
Publicado: (2023)

Fecal microbiota transplantation for irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials
por: Wang, Mancai, et al.
Publicado: (2023)

Fecal Microbiota Transplantation and the Brain Microbiota in Neurological Diseases
por: Ruggiero, Marco
Publicado: (2016)

Irritable bowel syndrome diagnosis
por: Tyllis, Nick
Publicado: (2019)

Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome
por: Tang, Binbin, et al.
Publicado: (2023)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Cui, Xiufang, et al.
Publicado: (2021)

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Lo Presti, Alessandra, et al.
Publicado: (2019)

Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome
por: Goll, Rasmus, et al.
Publicado: (2020)

Procedures in Fecal Microbiota Transplantation for Treating Irritable Bowel Syndrome: Systematic Review and Meta-Analysis
por: Rodrigues, Tânia, et al.
Publicado: (2023)

Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis
por: Halkjær, Sofie Ingdam, et al.
Publicado: (2023)

Efficacy and safety of fecal microbiota transplant in irritable bowel syndrome: An update based on meta‐analysis of randomized control trials
por: Abdelghafar, Yomna Ali, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g4ff6n3tmfra3d114efi89a179